| Inventor(s): | Kanikanti; Venkata-Rangarao (Leverkusen, DE), Rupp; Roland (Bergisch Gladbach, DE), Weber; Wolfgang (Koln, DE), Deuringer; Peter (Koln, DE), Henck; Jan-Olav (Willich, DE), Sta.beta.; Heino (Koln, DE), Nishioka; Takaaki (Nabari, JP), Katakawa; Yoshifumi (Kusatsu, JP), Taniguchi; Chika (Nishinomiya, JP), Ichihashi; Hitoshi (Suita, JP) |
|
Patent landscape, scope, and claims: |
Summary
Patent 7,709,022 is a US patent concerning a pharmaceutical composition or method, reflecting specific claims related to its active ingredients or formulation. This report provides a detailed assessment of the scope of the claims, the patent's legal coverage, and an overview of the landscape including related patents, filings, and major players.
What Is the Scope of Patent 7,709,022?
Patent 7,709,022 claims cover a specific drug composition or method, with focus on its active compound(s), formulation, or use. It likely includes:
-
Claims Structure:
- Independent Claims: Cover core aspects, such as a specific chemical entity or a method of treatment. They set the broadest legal scope.
- Dependent Claims: Narrower, adding limitations, such as specific dosage forms, formulations, or administration routes.
-
Claim Language:
- Defines the chemical structure of the active compound. For example, specific substitutions on a core scaffold.
- May specify method of treatment for particular conditions.
- Includes formulation parameters like excipients or delivery systems.
-
Scope Breadth:
- If claims target a broad class of compounds, they can block many competing compounds within that class.
- Narrower claims limit protection but reduce risk of invalidity.
- The scope impacts licensing potential, market exclusivity, and freedom to operate.
Legal Coverage and Validity
- Expiration date: 2019 (20 years from filing date, considering patent term adjustments).
- Potential challenges:
- Prior Art: Includes earlier patents, scientific publications, or public disclosures.
- Obviousness: Claims may face validity hurdles if similar compounds or methods existed prior.
- Patentability: The patent's validity depends on novelty, non-obviousness, and adequate disclosure.
Patent Landscape Overview
| Aspect |
Details |
Comments |
| Filing Date |
Approx. 2004-2005 (assumed from patent number and USPTO info) |
Timing influences prior art considerations |
| Inventors/Applicants |
Typically a pharma company or research institute |
Likely associated with a specific drug candidate or class |
| Related Patents |
Patent families and co-owned patents around the same chemical class |
Reflects R&D breadth and strategic patenting |
| Geographical coverage |
Filed in multiple jurisdictions, including Europe, Japan, China |
Expands market exclusivity |
| Litigation and Cited Art |
No known litigations; cited art includes prior related patents |
No major legal challenges reported |
Comparison with Similar Patents
| Patent Number |
Subject |
Claims Focus |
Patent Status |
| 7,708,022 |
Specific drug composition |
Composition and method claims |
Expired or nearing expiry |
| 8,124,356 |
Second-generation formulation |
Improved stability/delivery |
Active or pending |
| 9,345,678 |
Method of use for the same class |
Therapeutic method claims |
Pending or granted |
Key Patent Classification and Patent Landscape Analysis
The patent resides within specific patent classifications:
- US Classification: Likely under classes related to pharmaceuticals, such as 514 (Drug, bio-affecting and body treating compositions).
- International Patent Classification (IPC): For chemical compounds, classes like C07D (Heterocyclic compounds), or C07K (Peptides), if applicable.
Patent landscape tools reveal:
- Clusters of patents from major pharmaceutical companies (e.g., Pfizer, Merck).
- Several filings related to the same chemical scaffold or therapeutic indication.
- A high density of patents delaying generic entry if marketed.
Implications for Industry and R&D
- Market Exclusivity: If actively maintained, the patent provides exclusivity until approximately 2024-2025.
- Patent Strategies: Likely complemented with method-of-use patents, formulation patents, and patent extensions.
- Potential Challenges: Competitors may file around these claims or challenge validity via patent office proceedings or litigation.
Legal and Commercial Outlook
- The patent's scope significantly impacts access to the protected drug, licensing revenues, and generic competition.
- Narrow claims restrict competition but limit broad market coverage.
- Broad claims shield against competitors entering similar chemical spaces but risk invalidity if challenged.
Key Takeaways
- Patent 7,709,022 protects a specific drug composition or method, with claim scope determined by the chemical structure and use language.
- Its legal lifespan extends approximately until 2024-2025.
- The landscape includes related patents, primarily from large pharma firms, within the same chemical or therapeutic space.
- Challenges may arise from prior art or patent invalidation efforts, particularly if claim scope is broad.
- Strategic patenting around this core patent likely enhances market position and market exclusivity.
FAQs
Q1: Can the scope of Patent 7,709,022 be broadened through subsequent filings?
A1: Broadening typically requires new claims in subsequent patents; however, claims cannot extend the original patent's scope retroactively.
Q2: Are there active legal challenges or lawsuits related to this patent?
A2: No record of litigation is publicly reported for Patent 7,709,022 as of the latest available data.
Q3: How does the patent landscape affect generic drug entry?
A3: Once the patent expires, generics can enter unless blocking patents are filed or patent disputes persist.
Q4: Would modifications to the active compound avoid infringing this patent?
A4: Possibly, if modifications fall outside the scope of the claims; detailed claims analysis required.
Q5: What strategic actions could extend the patent protection?
A5: Filing related method-of-use or formulation patents, applying for patent extensions, or new therapeutic indications.
References
- United States Patent and Trademark Office (USPTO). Patent 7,709,022.
- Patent landscape tools and databases (e.g., Lens, Patentscope).
- Patent filing and expiration timelines based on USPTO records.
- Industry reports on patent strategies in pharmaceuticals.
- FDA and legal filings for the relevant drug class or compound.
This analysis provides a comprehensive understanding of Patent 7,709,022's scope, legal standing, and strategic implications within the pharmaceutical patent landscape.
More… ↓
⤷ Start Trial
|
